Dr. Lewis Thomas’ Journey from Clinical Practice to Sickle Cell Education
Published: 06 Jul 2026
For Lewis, medicine had never been just a career. Having lived with sickle cell himself, he knew what it felt like to be the patient in the room, and he wanted to become the kind of doctor he had needed growing up. Instead, he found himself working within a system that limited the impact he could have on what mattered most.
He became a general practitioner in the UK in 2019, stepping into a healthcare system already under strain, watching patients move in circles while clinicians worked with too little time and too few resources to change the outcome. “I felt like I was a really good doctor,” he says. “But because I didn’t have the resources, like time and being able to get people specialized treatments, it just felt like I was failing.”
Even as a junior doctor, the stress of the job was already triggering more frequent sickle cell crises than he had growing up. Then COVID-19 deepened his dissatisfaction: watching senior leadership tick boxes without engaging with what patients actually needed made it harder to imagine continuing in the career.
“I’d just started my career, but I knew this wasn’t what I wanted to do for the rest of my life,” he says. “If I do this for another twenty years, I’m just gonna be sick, and I’m gonna be miserable.” That realization made the choice clear. Staying any longer would mean trading his own health for a system that wasn’t built to work.
By August 2024, he had stepped away from clinical practice.
The Hospital Visit That Changed Lewis’ Direction
He moved into personal development coaching, helping others work through challenges and reach their goals. Months later, in March 2025, sickle cell reminded him why his path had changed. For the first time in ten years, Lewis was admitted to the hospital with a sickle cell crisis. This time, he wasn’t the doctor walking into the room. He was the patient lying in the bed.
What he found was painfully familiar: “Sickle cell patients still not understood, still not getting the right treatment, timely pain relief, all the things.” That experience reaffirmed the direction Lewis had already chosen: to focus on bridging the gap between patients and doctors.
The Gap Between Patients and Doctors
Lewis describes the gap from both sides, limited medical education on one side, a lack of trust on the other. Repeated, fragmented care also shapes perception: some doctors begin to view frequent admissions with skepticism rather than as part of a chronic condition.
Lewis knows that suspicion firsthand. “I’ve been in the position myself, as a young medical student, where I’ve clearly been seen as a drug seeker,” he says. His response is direct: “Unless you can physically go inside someone’s body and feel what they’re feeling, you just need to accept that they are in pain.”
Patients also rarely see the same doctor twice, so trust never has the chance to build. The result is a cycle where patients arrive expecting disbelief, and clinicians respond with caution. Neither side gets what it needs.
He also points to hydroxyurea, a medication that can significantly reduce complications, yet still goes untaken by most patients who could benefit from it.
For Lewis, the issue is rarely the drug itself but how, or whether, it gets explained. “If you’re offering hydroxyurea as a doctor, you can’t simply call it a ‘chemotherapy drug’ and expect someone to use it,” he says. A single word that signals cancer to most people is often enough to end the conversation before it starts.
Building Sickleverse
While still attending follow-up appointments after leaving clinical practice, he met a woman who knew very little about her own condition. That conversation stayed with him, reminding him of every other person managing sickle cell without the knowledge or tools to do so safely or even the confidence to publicly mention they live with it.
This led to Sickleverse, a platform that started as short educational videos and is growing into a community built on trust, where people living with sickle cell can ask questions without feeling alone. Through masterclasses on complications and a course in development for parents and carers, Sickleverse helps patients build the confidence to manage their condition before a crisis hits, while equipping families to recognize warning signs early.
Lewis envisions Sickleverse becoming the largest global community for sickle cell education and support, where access to understanding and treatment is not determined by geography, hospital access, or circumstance.
Collaboration, for him, means working with people whose strengths complement his own, freeing him to focus on what he loves doing: education and trust while partnering with others to build and scale what he cannot handle alone.
His journey shows the impact that lived experience, combined with clinical expertise, can have in reshaping how sickle cell disease is understood and cared for and his contribution to the sickle cell community is exactly the kind of work this series exists to recognize.
